HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription.

AbstractAIMS/HYPOTHESIS:
Sterol regulatory element binding protein-1c (SREBP-1c) is a master regulator of fatty acid synthase and controls lipogenesis. IRS-1 is the key insulin signalling mediator in skeletal muscle. In the present study, we investigated the role of SREBP-1c in the regulation of IRS-1 in skeletal muscle cells.
METHODS:
L6 muscle cells were treated with palmitic acid (PA) or metformin. Adenovirus vectors expressing Srebp-1c (also known as Srebf1) and small interfering RNA (siRNA) against Srebp-1c were transfected into the L6 cells. Protein-DNA interactions were assessed by luciferase reporter analysis, electrophoretic mobility shift assay and chromatin immunoprecipitation assay.
RESULTS:
We found that both gene and protein expression of SREBP-1c was increased in contrast to IRS-1 expression in PA-treated L6 cells. SREBP-1c overproduction decreased Irs-1 mRNA and IRS-1 protein expression in a dose-dependent manner, and suppressed the resultant insulin signalling, whereas SERBP-1c knockdown by Serbp-1c siRNA blocked the downregulation of IRS-1 induced by PA. Protein-DNA interaction studies demonstrated that SREBP-1c was able to bind to the rat Irs-1 promoter region, thereby repressing its gene transcription. Of particular importance, we found that metformin treatment downregulated Srebp-1c promoter activity, decreased the specific binding of SREBP-1c to Irs-1 promoter and upregulated Irs-1 promoter activity in PA-cultured L6 cells.
CONCLUSIONS/INTERPRETATION:
Our data indicate for the first time that SREBP-1c activation participates in skeletal muscle insulin resistance through a direct effect of suppressing Irs-1 transcription. These findings imply that SREBP-1c could serve as an attractive therapeutic target for insulin resistance.
AuthorsYan Bi, Wenjun Wu, Junfeng Shi, Hua Liang, Wenwen Yin, Yingying Chen, Sunyinyan Tang, Shu Cao, Mengyin Cai, Shanmei Shen, Qian Gao, Jianping Weng, Dalong Zhu
JournalDiabetologia (Diabetologia) Vol. 57 Issue 3 Pg. 592-602 (Mar 2014) ISSN: 1432-0428 [Electronic] Germany
PMID24362725 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoglycemic Agents
  • Insulin Receptor Substrate Proteins
  • Intracellular Signaling Peptides and Proteins
  • Irs1 protein, rat
  • Sterol Regulatory Element Binding Protein 1
  • Metformin
Topics
  • Adenoviridae
  • Animals
  • Blotting, Western
  • Cells, Cultured
  • Diet, High-Fat
  • Hypoglycemic Agents (pharmacokinetics)
  • Insulin Receptor Substrate Proteins (metabolism)
  • Insulin Resistance
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • Metformin (pharmacology)
  • Muscle, Skeletal (metabolism)
  • Promoter Regions, Genetic
  • Rats
  • Rats, Sprague-Dawley
  • Sterol Regulatory Element Binding Protein 1 (drug effects, metabolism)
  • Transcriptional Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: